PMC:7126544 / 62339-62467
Annnotations
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T31449 | 12-23 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
| T45116 | 84-95 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
| T99826 | 106-121 | Chemical | denotes | anti-viral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T75251 | 117-121 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T495 | 25-101 | Sentence | denotes | And in Guan's study, 35.8% (393/1099) of patients received oseltamivir [85]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1598 | 66-74 | Species | denotes | patients | Tax:9606 |
| 1608 | 12-23 | Chemical | denotes | oseltamivir | MESH:D053139 |
| 1609 | 84-95 | Chemical | denotes | oseltamivir | MESH:D053139 |